Approaches for optimal sequential decision analysis in clinical trials

Biometrics

Volumn 54, Issue 3, 1998, Pages 964-975

  Carlin, Bradley P ^a   Kadane, Joseph B ^b   Gelfand, Alan E ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Backward induction; Indifference zone; Interim monitoring; Monte Carlo methods

Indexed keywords

BAYESIAN NETWORKS; DECISION THEORY; MEDICAL APPLICATIONS;

BACKWARD INDUCTION; CLINICAL TRIAL; FORWARD SAMPLING; INDIFFERENCE ZONE; INTERIM MONITORING; LOSS FUNCTIONS; MONTECARLO METHODS; OPTIMAL SEQUENTIAL; SEQUENTIAL DECISIONS; TRADITIONAL APPROACHES;

MONTE CARLO METHODS;

ARTICLE; BAYES THEOREM; DATA ANALYSIS; DECISION MAKING; MATHEMATICAL COMPUTING; SYSTEM ANALYSIS;

EID: 0031683608     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533849     Document Type: Article

References (22)

1. Berry, D. A. (1991). Experimental design for drug development: A Bayesian approach. Journal of Biopharmaceutical Sciences 1, 81-101.
2. Berry, D. A. (1993). A case for Bayesianism in clinical trials (with discussion). Statistics in Medicine 12, 1377-1404.
3. Berry, D. A. (1995). Discussion of "Elicitation, monitoring, and analysis for an AIDS clinical trial," by B. P. Carlin, K. M. Chaloner, T. A. Louis, and F. S. Rhame. In Case Studies in Bayesian Statistics, Volume II, C. Gatsonis, J. S. Hodges, R. E. Kass, and N. D. Singpurwalla (eds), 78-85. New York: Springer-Verlag.
4. Berry, D. A. and Ho, C.-H. (1988). One-sided sequential stopping boundaries for clinical trials: A decision-theoretic approach. Biometrics 44, 219-227.
5. Besag, J. (1986). On the statistical analysis of dirty pictures (with discussion). Journal of the Royal Statistical Society, Series B 48, 259-302.
6. Carlin, B. P. and Louis, T. A. (1996). Identifying prior distributions that produce specific decisions, with application to monitoring clinical trials. In Bayesian Analysis in Statistics and Econometrics: Essays in Honor of Arnold Zellner, D. Berry, K. Chaloner, and J. Geweke (eds), 493-503. New York: Wiley.
7. Carlin, B. P. and Sargent, D. J. (1996). Robust Bayesian approaches for clinical trial monitoring. Statistics in Medicine 15, 1093-1106.
8. Carlin, B. P., Chaloner, K., Church, T., Louis, T. A., and Matts, J. (1993). Bayesian approaches for monitoring clinical trials with an application to toxoplasmic encephalitis prophylaxis. The Statistician 42, 355-367.
9. DeGroot, M. H. (1970). Optimal Statistical Decisions. New York: McGraw-Hill.
10. Hardwick, J. P. and Stout, Q. F. (1998). Using path induction to evaluate sequential allocation procedures. SIAM Journal of Scientific and Statistical Computing, in press.
11. Jacobson, M. A., Besch, C. L., Child, C., et al. (1994). Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: Results of a randomized trial. Journal of Infectious Diseases 169, 384-394.
12. Kadane, J. B. (1986). Progress toward a more ethical method for clinical trials. Journal of Medicine and Philosophy 11, 385-404.
13. Kadane, J. B. (1996). Bayesian Methods and Ethics in Clinical Trial Design. New York: Wiley.
14. Kadane, J. B. (1997). Discussion of "Robust Bayesian design and analysis of clinical trials via prior partitioning," by D. J. Sargent and B. P. Carlin. In Bayesian Robustness, J. O. Berger, B. Betro, E. Moreno, L. R. Pericchi, F. Ruggeri, G. Salinetti, L. Wasserman (eds). IMS Lecture Notes-Monograph Series 29, 190-191.
15. Kadane, J. B. and Sedransk, N. (1980). Toward a more ethical clinical trial (with discussion). In Bayesian Statistics, J. M. Bernardo, M. H. DeGroot, D. V. Lindley, and A. F. M. Smith (eds), 329-346. Valencia, Spain: University Press.
16. Lehmann, E. L. (1986). Testing Statistical Hypotheses, 2nd edition. New York: Wiley.
17. Lewis, R. J. and Berry, D. A. (1994). Group sequential clinical trials: A classical evaluation of Bayesian decision-theoretic designs. Journal of the American Statistical Association 89, 1528-1534.
18. Lindley, D. V. (1994). Discussion of "Bayesian approaches to randomised trials," by D. J. Spiegelhalter, L. S. Freedman, and M. K. B. Parmar. Journal of the Royal Statistical Society, Series A 157, 393.
19. Morris, C. N. (1983). Natural exponential families with quadratic variance functions: Statistical theory. Annals of Statistics 11, 515-529.
20. Spiegelhalter, D. J., Freedman, L. S., and Parmar, M. K. B. (1994). Bayesian approaches to randomised trials (with discussion). Journal of the Royal Statistical Society, Series A 157, 357-416.
21. Stangl, D. K. (1995a). Bayesian methods in the analysis of clinical trials: A discussion. In Proceedings of the Section on Bayesian Statistical Science, 7-9. Alexandria, Virginia: American Statistical Association.
22. Stangl, D. K. (1995b). Prediction and decision making using Bayesian hierarchical models. Statistics in Medicine 14, 2173-2190.